Relief from the nasal symptoms of allergy


mometasone furoate


Prescription strength!Once daily*

*one dose of 1 to 2
sprays in each nostril
newPOM to P Training

Relief from the nasal symptoms of allergy

Clarinaze Allergy Control 0.05% nasal spray, a hayfever treatment containing mometasone furoate, is now available from pharmacy without a prescription.

There are currently several over-the-counter (OTC) products to help customers with hayfever symptoms.
These include oral antihistamines, eye drops and intranasal corticosteroids (INS).

As mometasone furoate is newly switched from POM to P, it's crucial for the whole pharmacy team to know about Clarinaze Allergy Control 0.05% nasal spray, how it fits alongside current treatment options, and when it's appropriate to recommend.

Learning objectives

  • Understand the importance of pharmacy in advising on minor ailments such as hayfever
  • Recognise key features of NEW Clarinaze Allergy Control 0.05% nasal spray to help with customer conversations

Content developed by Bayer Consumer Health working together with
© 2020 CIG Healthcare Partnership.

Product information available at the end of the module.

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.